250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors

A list of 50 angel investors and VC funds that invest in Medical startups. We rank investors based on the number of investments they made in Medical companies. This investor list updates every month.

Top 50 Medical Startup Investors

Investor Medical investments
Innova Memphis 58
OrbiMed 45
New Enterprise Associates 43
ARCH Venture Partners 40
Bpifrance 37
F-Prime Capital 36
Polaris Partners 36
Qiming Venture Partners 35
Connecticut Innovations 34
Versant Ventures 33
Sequoia Capital China 31
Third Rock Ventures 29
Khosla Ventures 29
Alumni Ventures 29
Canaan Partners 29
Enterprise Ireland 29
Novo Holdings 28
Sofinnova Partners 28
Atlas Venture 28
Wisconsin Investment Partners 27
Wavemaker 360 27
BioVenture 25
BioAdvance 25
Lux Capital 24
Green Park & Golf Ventures 24
General Catalyst 23
Rock Health Capital 23
MB Venture Partners 22
Google Ventures 22
M Ventures 22
Parkwalk Advisors 22
Right Side Capital Management 22
Gaingels 22
StartUp Health 22
Houston Angel Network 21
KdT Ventures 21
UK Innovation & Science Seed Fund 21
Legend Capital 21
Deepbridge Capital 20
Alexandria Venture Investments 20
Portfolia 20
HealthCap 20
Boehringer Ingelheim Venture Fund 20
HTGF | High-Tech Gruenderfonds 20
Sanofi Ventures 19
MPM Capital 19
Scottish Enterprise 19
Novartis Venture Fund 19
TEDCO 19
Oxford Science Enterprises 19
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Innova Memphis VC Fund · Memphis, Tennessee, United States · 2 investments in the past 12 months
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Pre-Seed, Convertible Note
  • United States, Argentina, United Kingdom
Portfolio highlights
  • Rantizo — Fly more acres, deliver better service. The equipment, tools, and expertise you need to be the grower's first call for drone spray services.
  • iYOTAH Solutions — iYOTAH Solutions is a transformational SaaS technology company that connects data to help the animal protein industry thrive.
  • Glanris — Glanris developed a completely green, non-toxic, filtration media for water purification from an agriculture by-product. This agricultural product is grown around the world, is plentiful, and can be used locally to ensure clean drinking water in developing countries. It also gives local farmers a significant additional income source for a productthat today they are throwing away.This media has been independently tested over the last two years of development and is ready for production.
OrbiMed VC Fund · New York, New York, United States · 46 investments in the past 12 months
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, China, Israel
Portfolio highlights
  • TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
  • Corvus Pharmaceuticals — Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
  • Sparrow Pharmaceuticals — Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess.
New Enterprise Associates VC Fund · Menlo Park, California, United States · 39 investments in the past 12 months
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series B, Series A, Series C
  • United States, India, China
Portfolio highlights
  • beehiiv — Access the best tools available in email, helping your newsletter scale and monetize like never before.
  • SafeBase — Share your security posture with customers. Automate access to sensitive security and compliance documents with SafeBase.
  • ARRIS — ARRIS is an industrial engineering company that specializes in the fields of machinery manufacturing, automotive, and aerospace. It provides next-gen composites for mass-market applications including aerospace, automotive, sports, and consumer products. The company was founded in 2017 and headquartered in Berkeley, California.
ARCH Venture Partners VC Fund · Chicago, Illinois, United States · 19 investments in the past 12 months
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, China, United Kingdom
Portfolio highlights
  • Vilya — Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.
  • Metsera — Metsera operates as a clinical-stage biopharmaceutical company.
  • Xaira Therapeutics — Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research tobetter understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 71 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Switzerland
Portfolio highlights
  • FlexAI — We are unlocking the future of Machine Intelligence by rearchitecting the compute infrastructure
  • 52 Hertz — 52 Hertz has developed the Talkie-Divy, an underwater communications device that enhances safety, fun, and enjoyment in scuba diving, incorporating technologies directly adaptable to scuba diving regulators, while also considering environmental issues.
  • Docent — Docent is the first AI-powered mobile application to offer a fully-personalized experience for discovering, accessing and collecting contemporary masterpieces.
F-Prime Capital VC Fund · Cambridge, Massachusetts, United States · 33 investments in the past 12 months
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • United States, United Kingdom, China
Portfolio highlights
  • Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
  • Expressable — Expressable is an online speech therapy practice for everyone with a communication disorder. It has pioneered a parent-focused care model that uses technology and education to integrate speech therapy techniques into children's daily lives, improving outcomes and experiences.The company was founded in 2019 and is headquartered in Austin,Texas.
  • Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
Polaris Partners VC Fund · Boston, Massachusetts, United States · 20 investments in the past 12 months
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Ireland, Singapore
Portfolio highlights
  • Lore — Lore Health is a startup that combines artificial intelligence (AI) technology with social media to build a welcoming, encouraging, and judgment-free community where individuals may meet others who share their interests.
  • ByHeart — ByHeart operates as a fully integrated infant nutrition company. It is dedicated to translating leading nutrition science and breastmilk research into evolved foods and formulas to support babies’ health and parents’ peace of mind. Its products strive to be next to nature made from hand-picked ingredients using small-batch blending and sit at theforefront of immune, microbiome, cognitive, and digestive health.The company was founded in 2016 and is headquartered in New York.
  • Capstan Therapeutics — Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 44 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Ruining Bio — Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.
  • Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
  • Silicon Yi Technology — Silicon Yi Technology is an RNA nano-pesticide research and development firm.
Connecticut Innovations VC Fund · Rocky Hill, Connecticut, United States · 13 investments in the past 12 months
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Seed, Funding Round
  • United States, Israel, Canada
Portfolio highlights
  • Conduce Health — Conduce Health is a multi-specialty value-based care marketplace providing turnkey solutions for primary care organizations.
  • DeepLook Medical — Enhancing Medical Imaging with Revolutionary Software: DeepLook Medical envisions a future where data-driven imaging enables accurate, efficient, and personalized care across the entire treatment pathway.
  • Manifest Technologies — Manifest Technologies advances AI-powered computational neuroimaging system that quantifies neural and symptom data.
Versant Ventures VC Fund · Menlo Park, California, United States · 7 investments in the past 12 months
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Switzerland, Canada
Portfolio highlights
  • Firefly Bio — Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
  • SixPeaks Bio — SixPeaks is developing a pipeline of medicines for healthy weight loss.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Sequoia Capital China VC Fund · Beijing, Beijing, China · 32 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Biotechnology, Health Care, Artificial Intelligence
  • Series A, Series B, Series C
  • China, United States, Australia
Portfolio highlights
  • Black Jade Star Rock — Black Jade Star Rock develops organoid-based intelligent equipment and chips. It is a biomedical research and development company with organoid science as its fundamental technology.
  • Moonshot AI — Dark Side of the Moon is an AI large-scale model company.
  • Membrane Biofilm Technology — Membrane Biofilm Technology is a membrane filtration company that specializes in the development, production, and solutions of membrane filtration products.
Third Rock Ventures VC Fund · Boston, Massachusetts, United States · 3 investments in the past 12 months
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States
Portfolio highlights
  • Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
  • Seaport Therapeutics — Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
  • Synnovation Therapeutics — Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, andpatient-focused precision medicine, it builds a diverse pipeline of novel small-molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.
Khosla Ventures VC Fund · Menlo Park, California, United States · 75 investments in the past 12 months
Khosla Ventures invests in companies that are bold, early and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. Headquartered in Menlo Park, Calif., Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech,digital health, medtech and diagnostics, therapeutics and frontier technology.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, India, United Kingdom
Portfolio highlights
  • Karius — Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a majorthreat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.
  • Zeck — Create smarter, modern board updates optimized for superior readability to better engage and inform your board and investors. Run perfect board meetings.
  • YonedaLabs — Yoneda Labs suggests Reaction Conditions that work with no wet lab experimentation, and then we can help you optimise too, if necessary.
Alumni Ventures VC Fund · Manchester, New Hampshire, United States · 134 investments in the past 12 months
Alumni Ventures offers diversified venture portfolios to accredited investors into highly competitive deals that individuals typically do not have access to on their own.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Series B
  • United States, United Kingdom, Canada
Portfolio highlights
  • UserHub — UserHub is a pricing tool based on users that assists SaaS firms in selling more seats.
  • NANOCHON — 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:"
  • ARRIS — ARRIS is an industrial engineering company that specializes in the fields of machinery manufacturing, automotive, and aerospace. It provides next-gen composites for mass-market applications including aerospace, automotive, sports, and consumer products. The company was founded in 2017 and headquartered in Berkeley, California.
Canaan Partners VC Fund · Menlo Park, California, United States · 11 investments in the past 12 months
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, Israel, United Kingdom
Portfolio highlights
  • Cynomi — Cynomi addresses a critical gap in mid-market cyber protection - creating and executing a cyber and compliance strategy .
  • Qlaris Bio — Qlaris Bio focuses on developing novel and innovative therapies for serious and debilitating ophthalmic diseases. Qlaris Bio is a spinout company of Qrativ, a biotechnology incubator formed as a joint venture between Mayo Clinic and inference, a pharmaceutical-focused artificial intelligence company. Its lead program is QLS-101, a novel compoundinvented at Mayo Clinic and the University of Minnesota. QLS-101, with its unique and first-in-class mechanism of action, may potentially serve as an efficacious treatment for high unmet need conditions related to disturbances in intraocular pressure, including a sight-threatening and progressive Pediatric Rare Disease for which effective therapies remain elusive and limited.Qlaris Bio was founded in 2019 and is headquartered in Cambridge, Massachusetts.
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Enterprise Ireland VC Fund · Dublin, Dublin, Ireland · 12 investments in the past 12 months
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Lative — Lative automates capacity planning, maximizing profitable sales growth & revenue efficiency for high-performance revenue teams.
  • Cytidel — Cytidel helps security teams reduce breaches, save time, and stay secure. Vulnerability Management and Cyber Risk Management, and Threat Intelligence Specialists
  • Positive Carbon — Positive Carbon provides an innovative solution for businesses to track, manage, and reduce food waste. With real-time analytics, CO2 calculation, and a comprehensive learning platform, we help you save costs and achieve sustainability goals. Request a demo today to start making a positive environmental impact.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 9 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
  • Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
  • Reunion Neuroscience — Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable antidepressant for patients suffering from postpartum depressionand other mental health conditions. Reunion is also developing the RE200 series, which includes compounds with the potential for more selective serotonin receptor activity and reduced psychoactivity for application in more chronic treatment paradigms and indications.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 23 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Cure51 — Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
  • May Health — AblaCare develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility, designed to provide patients with a more natural and less medicalised pregnancy experience.AblaCare aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. AblaCare's procedure is donetransvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Atlas Venture VC Fund · Cambridge, Massachusetts, United States · 11 investments in the past 12 months
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, United Kingdom, Canada
Portfolio highlights
  • Korro Bio — Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in proteinstructure and function across multiple tissues.In 2018,
  • Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
  • Diagonal Therapeutics — Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate critical biological pathways for transformative patient outcomes.
Wisconsin Investment Partners VC Fund · Madison, Wisconsin, United States · 2 investments in the past 12 months
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members. Membership has grown to 50+ members in recent years, bringing significant knowledge and experience.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Seed, Series A
  • United States, Canada, United Kingdom
Portfolio highlights
  • Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
  • BeeReaders — ## Build Setup
  • Midwest Games — Midwest Games is a video game publisher focused on creating opportunities for the abundant talent across the Midwest and other underrepresented regions.
Wavemaker 360 VC Fund · Pasadena, California, United States · 5 investments in the past 12 months
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Canada
Portfolio highlights
  • Elektra Health — Evidence-based menopause expertise & care because you deserve better
  • Pear Bio — Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
  • Nest Collaborative — Nest Collaborative offers online lactation consults. Virtual appointments are available same-day & are covered in full by most insurance plans.
BioVenture VC Fund · Suzhou, Jiangsu, China · 7 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
  • Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
  • Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.
BioAdvance VC Fund · Philadelphia, Pennsylvania, United States
BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United States, Canada
Portfolio highlights
  • Senzo — SENZO HEALTH HAS DEVELOPED A REVOLUTIONARY LATERAL FLOW TEST WHICH DELIVERS THE SAME ACCURACY AS LABORATORY-BASED PCR, WITH RESULTS AVAILABLE WITHIN 10 MINUTES, AT A FRACTION OF THE COST.
  • KayoThera — KayoThera is a biotechnology company developing therapeutics used to cure late-stage and metastatic cancers. Its programs work on inhibiting a key enzyme that is responsible for protecting the cancer cells and depleting regulatory T-cells that intends to cure hitherto incurable cancers and give hope to patients. The company's mission is todevelop the first-in-class immuno- and targeted therapies to drive cures in advanced cancersKayoThera was founded in 2019 and is headquartered in Princeton, New Jersey.
  • Palvella Therapeutics — Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
Lux Capital VC Fund · New York, New York, United States · 37 investments in the past 12 months
Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Seed, Series B
  • United States, Canada, United Kingdom
Portfolio highlights
  • Nominal — A faster, more reliable way to review test data for mission-critical systems.
  • Summer Health — Get answers from an expert, board-certified pediatricians in 15 minutes. From child health to development, Summer Health gets you answers any time, day or night.
  • Xaira Therapeutics — Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research tobetter understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.
Green Park & Golf Ventures VC Fund · Dallas, Texas, United States
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • United States, Israel, Sweden
Portfolio highlights
  • Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
  • Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.
General Catalyst VC Fund · Cambridge, Massachusetts, United States · 86 investments in the past 12 months
Investing in powerful, positive change that endures
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Seed, Series B
  • United States, United Kingdom, India
Portfolio highlights
  • EthonAI — The EthonAI Manufacturing Analytics System is a powerful software suite to achieve operational excellence at scale.
  • Faircado — Stop wasting time and money - faircado helps you find the best pre-owned deals for your wallet and the planet.
  • Literati — Based in Austin,Texas Literati is a subscription book club company. Since 2017, Literati has provided a unique try-before-you-buy book club service to kids 12 and under. Most recently the company has expanded its product line, offering book clubs curated by “luminaries,” a collection of authors, intellectuals, and other notable figures.Literati's team is made up of product people, perfectionistic designers, philosophical hackers, and straight-up hustlers on a mission to build revolutionary excitement in literature. The company was founded in 2017 and is based in Austin, Texas.
Rock Health Capital VC Fund · San Francisco, California, United States
We invest in remarkable entrepreneurs working at the intersection of healthcare and technology.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, Denmark
Portfolio highlights
  • WellTheory — Our programs support autoimmune lifestyle changes with an actionable and supportive membership experience, no matter where you are in your autoimmune journey.
  • Oula Health — Oula is a modern maternity clinic combining the best of obstetrics and midwifery care to deliver an evidence-based and personalized pregnancy experience
  • Rosarium Health — Rosarium Health is a platform that connects service providers (home contractors and occupational therapists) with customers to execute accessible house assessments and accessible home modifications at a client's primary home, leased property, or company.
MB Venture Partners VC Fund · Memphis, Tennessee, United States
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series B, Series C
  • United States, Israel
Portfolio highlights
  • Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
  • SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
  • Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
Google Ventures VC Fund · Mountain View, California, United States · 57 investments in the past 12 months
GV supports innovative founders moving the world forward.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Vercel — Vercel's Frontend Cloud gives developers the frameworks, workflows, and infrastructure to build a faster, more personalized web.
  • Verse — Define & achieve your financial and emissions reduction goals with Aria, a software platform that helps companies buy and manage clean power.
  • WitnessAI — WitnessAI - Enable safe, effective AI
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 16 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • LabGenius — Finding the next generation of drugs with machine learning, synthetic biology and laboratory automation
  • Outrun TX — Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
  • Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
Parkwalk Advisors VC Fund · London, England, United Kingdom · 7 investments in the past 12 months
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Philippines
Portfolio highlights
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Adsilico — Adsilico redefines medical device innovation.
  • Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
Right Side Capital Management VC Fund · San Francisco, California, United States · 8 investments in the past 12 months
Right Side Capital Management is a venture capital firm that helps startups build their company. It invests exclusively in the pre-seed round of technology startups and makes 75-100 investment per year. The firms prefers to invest in diversified technology sectors such as the internet and cloud companies.RSCM was established in 2010 and is basedin San Francisco, California.
Show more
Investment focus
  • Software, SaaS, Health Care
  • Seed, Pre-Seed, Convertible Note
  • United States, Canada, United Kingdom
Portfolio highlights
  • ASETS — ASETS develops software for engineers and created the first cloud-based Integrated Design Suite.
  • HLRBO — HLRBO is an online hunting network that connects landowners and hunters. List your property on HLRBO. No fees. No commissions. Hunters contact you directly with questions or to lease.
  • Precision Compounding — Precision Compounding compounds customized medications to meet the specific needs of patients and their pets. They benefit patients by providing formulations customized for dosage, taste, and ingredients. Their services include proscripts, concierge pick-up options, and professional delivery. They respond to customer inquiries by phone, contactform, and email.
Gaingels VC Fund · New York, New York, United States · 62 investments in the past 12 months
Gaingels is a leading venture investment syndicate in support of diversity, inclusive of the LGBTQIA+ community and allies in the venture capital space.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Series B
  • United States, Canada, Mexico
Portfolio highlights
  • Patlytics — Patent discovery, analytics, comparison, and workflow. Simplified via Artificial Intelligence.
  • ValidMind — ValidMind is the most efficient solution for governance & risk management of AI and LLMs. Automate model documentation and validation for all model types.
  • Summer​ — Summer partners with employers help their populations navigate and reduce student loan debt. Summer is a certified B-Corp.
StartUp Health VC Fund · New York, New York, United States · 2 investments in the past 12 months
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more
Investment focus
  • Health Care, Wellness, Medical
  • Seed, Funding Round, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Pear Suite — Pear Suite enables anyone—community health workers, other healthcare staff, and volunteers—to assess and address the social drivers of health for older adults in a scalable, cost-effective, and person-centered way.
  • Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
Houston Angel Network VC Fund · Houston, Texas, United States
The Houston Angel Network (HAN) is a nonprofit organization dedicated to developing the innovation ecosystem in Houston, Texas by supporting founders and startups with financial resources and mentorship.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • United States, Canada, United Kingdom
Portfolio highlights
  • CaseCTRL — Schedule surgeries with ease using AI-powered surgical scheduling. Fewer canceled cases, conflicts, and misorders. More surgery and time for patients!
  • Materna Medical — Materna Medical empowers women to protect and restore their pelvic health.
  • Amplified Sciences — Providing innovative diagnostic tests that enable earlier detection, risk stratification and monitoring of challenging diseases.
KdT Ventures VC Fund · Austin, Texas, United States · 6 investments in the past 12 months
KdT Ventures is the standard for early-stage frontier science investing.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United States, Israel, Germany
Portfolio highlights
  • Elegen — Elegen is powering the bioeconomy with high-accuracy DNA synthesis that delivers industry-leading speed, length, and quality.
  • Motif Neurotech — Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.
  • Radar Therapeutics — Precision-targeted, smart therapies to conquer the world's most intractable diseases.
UK Innovation & Science Seed Fund VC Fund · Harwell, Oxfordshire, United Kingdom · 12 investments in the past 12 months
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • ExactTrak — ExactTrak Embedded command and control of mobile devices, even when they are turned off.
  • Presymptom Health — Presymptom Health is a pioneering medtech company that creates diagnostic tests to detect illnesses earlier to help save lives.
  • Oxford Space Systems — Oxford Space Systems is a multi-award-winning, record-breaking venture capital backed, space tech business that's developing a new generation of deployable antennas and space structures for the global satellite industry. Using both innovative design techniques such as origami and novel proprietary materials developed by the company, OSS'structures are lighter, less complex and lower cost than alternatives in commercial demand. Founded in late 2013, OSS set a record for the space sector with it's AstroTube Boom: the fastest development of a new product from concept to successful deployment on orbit in under 30 months. Today, the 18 strong and growing OSS team is a diverse mix of international graduates and experienced space industry professionals, with over 100 years of combined space sector experience. OSS investors include a small syndicate of UK venture capital funds together US based investors, Space Angels. Oxford Space Systems has successfully completed a number of UK government supported co-developments with leading European satellite builders as well straight commercial contracts in both Asia and the US. As part of its planned expansion, OSS move into its own custom facility at the Harwell Space Cluster in August 2018, giving it the largest clean room at the cluster. The facility will meet required security standards to undertake UK government defense & security contracts. .
Legend Capital VC Fund · Beijing, Beijing, China · 28 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • MS Energy — MS Energy is a technology-driven enterprise that specializes in providing green energy solutions.
  • Dearer Medical — Dearer Medical is a medical device company that specializes in the development, production, and sales of eye-related medical products such as color contact lenses.
  • Zhongke Guosheng — Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.
Deepbridge Capital VC Fund · Chester, Cheshire, United Kingdom
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Australia, Singapore
Portfolio highlights
  • Circada — Innovative Circadian lighting reconnects the body clock with nature
  • Microplate Dx — Safeguarding against the spread of antimicrobial resistance worldwide.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Alexandria Venture Investments VC Fund · Pasadena, California, United States · 13 investments in the past 12 months
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, France, Canada
Portfolio highlights
  • Umaro Foods — Umaro Foods specializes in developing a plant-based protein source from ocean-farmed seaweed.
  • Tome Biosciences — Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
  • Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
Portfolia VC Fund · San Mateo, California, United States · 2 investments in the past 12 months
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Seed, Series A, Series B
  • United States, Canada, Argentina
Portfolio highlights
  • Attn: Grace — Attn: Grace is a sustainable wellness brand designed for women. Starting with bladder leakage, they're creating thoughtful, more sustainable solutions for life’s inconvenient truths, one challenge at a time.
  • Prime Roots — Prime Roots is on a mission to provide a better cut of meat for every type of eater. Rooted in koji, Prime Roots is able to replicate the taste and texture of meat without any of the environmental costs of animal proteins.
  • Harvest Thermal — We are manufacturers of the cleanest home energy solution on the market today. We offer a cloud-enabled, ultra-clean heating, cooling and hot water system for residential customers. The brains of the system is our award-winning Harvest Pod that slashes carbon emissions, saves on utility bills, and
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
  • Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 2 investments in the past 12 months
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
HTGF | High-Tech Gruenderfonds VC Fund · Bonn, Nordrhein-Westfalen, Germany · 49 investments in the past 12 months
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Graswald — Graswald engages in the creation of natural and digital 3D worlds for the entertainment industry.
  • Scavenger AI — Generative AI and Data Analytics for your daily business challenges. Scavenger uses Artificial Intelligence and Machine Learning Algorithms to power its 3 tools: Purity, Quantum and Prophecy. Purity cleans and harmonizes the data. Quantum runs statistical algorithms and analyzes the data. Prophecy d
  • CustomSurg — RETHINKING TRAUMA SURGERY At CustomSurg we are changing the treatment of complex bone fractures from a subjective to an objective approach, through personalized solutions.
Sanofi Ventures VC Fund · Cambridge, Massachusetts, United States · 10 investments in the past 12 months
Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, Israel
Portfolio highlights
  • Q32 Bio — Q32 Bio is developing drugs targeting powerful regulators of both the innate and adaptive immune systems with the goal of re-balancing the immune system.
  • Sudo Biosciences — Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class.
  • NextPoint Therapeutics — NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies.
MPM Capital VC Fund · Cambridge, Massachusetts, United States · 7 investments in the past 12 months
Powering Breakthroughs in Life Sciences
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, United Kingdom, Canada
Portfolio highlights
  • AstronauTx — AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
  • Firefly Bio — Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
  • Frontier Medicines — Frontier Medicines is boldly advancing science to defeat disease by pioneering innovations in precision-based medicines to target undruggable therapies
Scottish Enterprise VC Fund · Glasgow, Glasgow City, United Kingdom · 12 investments in the past 12 months
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Grant, Funding Round, Seed
  • United Kingdom, United States, Japan
Portfolio highlights
  • Nebu~Flow — Nebu~Flow develops the next generation of nebulisers to enable the delivery of life changing treatments.
  • QuickBlock — Interlocking blocks is the best way to summarise how QUICKBLOCK works to a novice. Our interlocking blocks click together to build desired structures.
  • Bright Ascension — Bright Ascension offers mission ready software in space and on the ground. Our integrated software is perfect for any satellite mission.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 4 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
  • Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
TEDCO VC Fund · Columbia, Maryland, United States · 15 investments in the past 12 months
TEDCO was created by the Maryland State Legislature in 1998 to facilitate the transfer and commercialization of technology from Maryland’s research universities and federal labs into the marketplace and to assist in the creation and growth of technology-based businesses in all regions of the State. TEDCO is an independent organization thatstrives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy. In Maryland and beyond, TEDCO is a resource of mentoring, funding and networking for entrepreneurs and start-ups that need guidance as they bring innovative concepts to market. TEDCO is more than an early stage funding resource. It is the hub of Maryland’s entrepreneurial network where startups find mentors, organizational assistance, facilities for daily operations, and a roadmap for success.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Pre-Seed, Grant
  • United States
Portfolio highlights
  • ReBokeh — ReBokeh is a mobile application that offers visually impaired video filters to enhance the users' vision.
  • PediaMetrix — Founded by alumni entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford, PediaMetrix’s mission is to bring AI and computer vision to pediatrics to lower the healthcare costs and improve outcomes. PediaMetrix’s lead product, SoftSpot, enables early detection and management of the most common conditions with head shape abnormalities innewborns. PediaMetrix is a Delaware company founded in 2018.
  • Escalate USA — At Escalate, we solve the talent crisis for retail corporations. We increase employee retention and the internal pool of skilled middle-wage candidates by providing frontline workers with weekly asynchronous online training that leads to industry-recognized certifications and upward mobility.
Oxford Science Enterprises VC Fund · Oxford, Oxfordshire, United Kingdom · 11 investments in the past 12 months
Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Finland
Portfolio highlights
  • Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
  • Oxford Endovascular — Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal.
  • Grey Wolf Therapeutics — By targeting the ERAP proteases in the antigen presentation pathway Grey Wolf aims to change the neoantigen repertoire in cancer.
Investors by industry
Investors by country
Investors in Medical by country
Angel investors in Medical by country
VC Funds in Medical by country